These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21961563)

  • 1. A retrospective cohort study of the potency of lipid-lowering therapy and race-gender differences in LDL cholesterol control.
    Turner BJ; Hollenbeak CS; Weiner M; Tang SS
    BMC Cardiovasc Disord; 2011 Sep; 11():58. PubMed ID: 21961563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Race-Sex Differences in Statin Use and Low-Density Lipoprotein Cholesterol Control Among People With Diabetes Mellitus in the Reasons for Geographic and Racial Differences in Stroke Study.
    Gamboa CM; Colantonio LD; Brown TM; Carson AP; Safford MM
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28490523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex differences in patient and provider response to elevated low-density lipoprotein cholesterol.
    Haskell SG; Bathulapalli H; Pham T; Goulet J; Skanderson M; Driscoll M; Brandt C; Dziura J
    Womens Health Issues; 2014; 24(5):575-80. PubMed ID: 25213750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dyslipidemia according to gender and race: The Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).
    Santos RD; Bensenor IM; Pereira AC; Lotufo PA
    J Clin Lipidol; 2016; 10(6):1362-1368. PubMed ID: 27919353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Joint effect of race/ethnicity or location of residence and sex on low density lipoprotein-cholesterol among veterans with type 2 diabetes: a 10-year retrospective cohort study.
    Weeda ER; Bishu KG; Ward R; Axon RN; Taber DJ; Gebregziabher M
    BMC Cardiovasc Disord; 2020 Oct; 20(1):449. PubMed ID: 33059602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective review of sex differences in the management of dyslipidemia in coronary heart disease: an analysis of patient data from a Maryland-based health maintenance organization.
    Cooke CE; Hammerash WJ
    Clin Ther; 2006 Apr; 28(4):591-9. PubMed ID: 16750470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender Disparities in Lipid-Lowering Therapy in Cardiovascular Disease: Insights from a Managed Care Population.
    Rodriguez F; Olufade TO; Ramey DR; Friedman HS; Navaratnam P; Heithoff K; Foody JM
    J Womens Health (Larchmt); 2016 Jul; 25(7):697-706. PubMed ID: 26889924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex disparity persists in the prevention of cardiovascular disease in women on statin therapy compared to that in men.
    Moreno-Arellano S; Delgado-de-Mendoza J; Santi-Cano MJ
    Nutr Metab Cardiovasc Dis; 2018 Aug; 28(8):810-815. PubMed ID: 29754716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding disparities in lipid management among patients with type 2 diabetes: gender differences in medication nonadherence after treatment intensification.
    Billimek J; Malik S; Sorkin DH; Schmalbach P; Ngo-Metzger Q; Greenfield S; Kaplan SH
    Womens Health Issues; 2015; 25(1):6-12. PubMed ID: 25442365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic predictors of response to simvastatin therapy among African-Americans and Caucasians: the Cholesterol and Pharmacogenetics (CAP) Study.
    Simon JA; Lin F; Hulley SB; Blanche PJ; Waters D; Shiboski S; Rotter JI; Nickerson DA; Yang H; Saad M; Krauss RM
    Am J Cardiol; 2006 Mar; 97(6):843-50. PubMed ID: 16516587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
    Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
    Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid-lowering therapy and low-density lipoprotein cholesterol goal attainment after acute coronary syndrome: a Danish population-based cohort study.
    Kristensen MS; Green A; Nybo M; Hede SM; Mikkelsen KH; Gislason G; Larsen ML; Ersbøll AK
    BMC Cardiovasc Disord; 2020 Jul; 20(1):336. PubMed ID: 32660429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors explaining the gender disparity in lipid-lowering treatment goal attainment rate in Chinese patients with statin therapy.
    Zhang R; Zhao L; Liang L; Xie G; Wu Y
    Lipids Health Dis; 2012 May; 11():59. PubMed ID: 22642757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid-lowering therapy and lipid goal attainment in patients with metabolic syndrome in China: subgroup analysis of the Dyslipidemia International Study-China (DYSIS-China).
    Wang F; Ye P; Hu D; Min Y; Zhao S; Wang Y; Mu Y; Yan X; Li Z; Wei Y; Li J;
    Atherosclerosis; 2014 Nov; 237(1):99-105. PubMed ID: 25238215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication Adherence Does Not Explain Black-White Differences in Cardiometabolic Risk Factor Control among Insured Patients with Diabetes.
    Lafata JE; Karter AJ; O'Connor PJ; Morris H; Schmittdiel JA; Ratliff S; Newton KM; Raebel MA; Pathak RD; Thomas A; Butler MG; Reynolds K; Waitzfelder B; Steiner JF
    J Gen Intern Med; 2016 Feb; 31(2):188-195. PubMed ID: 26282954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Dyslipidemia and Availability of Lipid-Lowering Medications Among Primary Health Care Settings in China.
    Lu Y; Zhang H; Lu J; Ding Q; Li X; Wang X; Sun D; Tan L; Mu L; Liu J; Feng F; Yang H; Zhao H; Schulz WL; Krumholz HM; Pan X; Li J;
    JAMA Netw Open; 2021 Sep; 4(9):e2127573. PubMed ID: 34586366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of ezetimibe added to ongoing statin therapy in modifying lipid profiles and low-density lipoprotein cholesterol goal attainment in patients of different races and ethnicities: a substudy of the Ezetimibe add-on to statin for effectiveness trial.
    Pearson TA; Denke MA; McBride PE; Battisti WP; Gazzara RA; Brady WE; Palmisano J
    Mayo Clin Proc; 2006 Sep; 81(9):1177-85. PubMed ID: 16970214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender and ethnic differences in the control of hyperlipidaemia and other vascular risk factors: insights from the CEntralised Pan-South African survey on tHE Under-treatment of hypercholeSterolaemia (CEPHEUS SA) study.
    Rapeport N; Schamroth CL; Blom DJ
    Cardiovasc J Afr; 2013 Jul; 24(6):238-42. PubMed ID: 24217264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What Do US Physicians and Patients Think About Lipid-Lowering Therapy and Goals of Treatment? Results From the GOULD Registry.
    Arnold SV; Cannon CP; de Lemos JA; Rosenson RS; Ballantyne CM; Liu Y; Alam S; Mues KE; Bhatt DL; Kosiborod M;
    J Am Heart Assoc; 2021 Aug; 10(16):e020893. PubMed ID: 34369165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethnic differences in achievement of cholesterol treatment goals. Results from the National Cholesterol Education Program Evaluation Project Utilizing Novel E-Technology II.
    Clark LT; Maki KC; Galant R; Maron DJ; Pearson TA; Davidson MH
    J Gen Intern Med; 2006 Apr; 21(4):320-6. PubMed ID: 16686806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.